FDA Approved: REVONTO — Supplemental Application (USWM, LLC)

View source ↗

Summary

FDA approved a supplemental application for REVONTO (dantrolene sodium) from USWM, LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Hyperthermia

Drugs mentioned

• REVONTO (Dantrolene Sodium)

Snippet

SUPPL AP for REVONTO (DANTROLENE SODIUM)